From Weeks To Minutes: How Intelligent Automation Transforms CQV Workflows
By Peter Liang, Solutions Engineer, ValGenesis

The commissioning, qualification, and validation (CQV) process is a pivotal phase in the journey from a promising production line to full-scale commercial supply in the life sciences industry. Despite the rapid pace of technological advancement, many companies in 2025 still rely on outdated methods—binders filled with paper documentation, wet-ink signatures, and manually updated spreadsheets—to demonstrate that their assets perform as intended. These legacy approaches not only prolong project timelines by weeks but also inflate costs and introduce unnecessary risks. Meanwhile, regulatory bodies such as the FDA, EMA, WHO, and PIC/S are placing increasing emphasis on data integrity, making the shortcomings of manual CQV processes even more pronounced.
Intelligent automation is reshaping this landscape. By integrating risk-based methodologies, AI-powered analytics, and seamlessly connected data systems, organizations can dramatically accelerate CQV timelines—from weeks to days, and in some cases, even minutes—without compromising compliance. This digital transformation is already taking root at leading global facilities, proving that speed and regulatory rigor can coexist when supported by the right technology.
In this article, we’ll delve into the limitations of traditional CQV practices, uncover how intelligent automation eliminates critical bottlenecks, and highlight the strategic advantages life sciences companies gain by embracing digital solutions.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.